+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Liver Disease Diagnostics Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • August 2026
  • Region: Global
  • Grand View Research
  • ID: 5914580
The global liver disease diagnostics market size was valued at USD 40.5 billion in 2025 and is projected to grow from USD 43.2 billion in 2026 to USD 66.4 billion by 2033, at a CAGR of 6.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 43.1% in 2025. The growth is primarily driven by the increasing prevalence of chronic liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), viral hepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma.

The adoption of non-invasive diagnostic technologies, molecular diagnostics, biomarker-based assays, and artificial intelligence-enabled imaging is strengthening early disease detection, improving diagnostic accuracy, and supporting informed clinical decision-making. These advancements, coupled with expanding liver disease screening programs, increasing investments in precision medicine, and continued product innovation by leading market participants, are expected to strengthen diagnostic capabilities and support sustained market growth.

Global Liver Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global liver disease diagnostics market report on the basis of diagnosis technique, disease, end-use, and region:

Diagnosis Technique Outlook (Revenue, USD Billion, 2021 - 2033)

  • Laboratory Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others

Disease Outlook (Revenue, USD Billion, 2021 - 2033)

  • NAFLD
  • NASH
  • Fibrosis
  • Cirrhosis
  • HCC
  • Others

End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospitals
  • Laboratories
  • Others

Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Diagnosis Technique Segment
1.2.2. Disease Segment
1.2.3. End-use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Global Liver Disease Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of metabolic and chronic liver diseases
3.2.1.2. Advancements in Diagnostic Technologies
3.2.1.3. Increasing Awareness and Early Detection
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Advanced Diagnostics
3.2.2.2. Limited Awareness in Developing Regions
3.2.3. Market opportunity analysis
3.3. Global Liver Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Global Liver Disease Diagnostics Market: Diagnosis Technique Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Liver Disease Diagnostics Market Diagnosis Technique Movement Analysis
4.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, Diagnosis Technique, 2021 to 2033 (USD Billion)
4.4. Imaging
4.4.1. Imaging market estimates and forecasts 2021 to 2033 (USD Billion)
4.5. Laboratory Tests
4.5.1. Laboratory Tests market estimates and forecasts 2021 to 2033 (USD Billion)
4.6. Endoscopy
4.6.1. Endoscopy market estimates and forecasts 2021 to 2033 (USD Billion)
4.7. Biopsy
4.7.1. Biopsy market estimates and forecasts 2021 to 2033 (USD Billion)
4.8. Others
4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Billion)
Chapter 5. Global Liver Disease Diagnostics Market: Disease Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Liver Disease Diagnostics Market Disease Movement Analysis
5.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, Disease, 2021 to 2033 (USD Billion)
5.4. NAFLD
5.4.1. NAFLD market estimates and forecasts 2021 to 2033 (USD Billion)
5.5. NASH
5.5.1. NASH market estimates and forecasts 2021 to 2033 (USD Billion)
5.6. Fibrosis
5.6.1. Fibrosis market estimates and forecasts 2021 to 2033 (USD Billion)
5.7. Cirrhosis
5.7.1. Cirrhosis market estimates and forecasts 2021 to 2033 (USD Billion)
5.8. HCC
5.8.1. HCC market estimates and forecasts 2021 to 2033 (USD Billion)
5.9. Others
5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Billion)
Chapter 6. Global Liver Disease Diagnostics Market: End-use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Liver Disease Diagnostics Market End-use Movement Analysis
6.2.1. Global Liver Disease Diagnostics Market Size & Trend Analysis, End-use, 2021 to 2033 (USD Billion)
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts 2021 to 2033 (USD Billion)
6.4. Laboratories
6.4.1. Laboratories market estimates and forecasts 2021 to 2033 (USD Billion)
6.5. Others
6.5.1. Others market estimates and forecasts 2021 to 2033 (USD Billion)
Chapter 7. Liver Disease Diagnostics Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Billion)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Billion)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Billion)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Billion)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Billion)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Billion)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Billion)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Billion)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Billion)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Billion)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Billion)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Billion)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Billion)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Billion)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Billion)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Billion)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Billion)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Billion)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Billion)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Billion)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Billion)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Billion)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2025
8.4. List of Key Certification Providers/Scheme Owners
8.5. Company Profiles/Listing
8.5.1. Abbott
8.5.1.1. Company overview
8.5.1.2. Financial performance
8.5.1.3. Product benchmarking
8.5.1.4. Strategic initiatives
8.5.2. F. Hoffmann-La Roche Ltd.
8.5.2.1. Company overview
8.5.2.2. Financial performance
8.5.2.3. Product benchmarking
8.5.2.4. Strategic initiatives
8.5.3. Thermo Fisher Scientific Inc.
8.5.3.1. Company overview
8.5.3.2. Financial performance
8.5.3.3. Product benchmarking
8.5.3.4. Strategic initiatives
8.5.4. Randox Laboratories Ltd
8.5.4.1. Company overview
8.5.4.2. Financial performance
8.5.4.3. Product benchmarking
8.5.4.4. Strategic initiatives
8.5.5. Boston Scientific Corporation
8.5.5.1. Company overview
8.5.5.2. Financial performance
8.5.5.3. Product benchmarking
8.5.5.4. Strategic initiatives
8.5.6. Laboratory Corporation of America Holdings
8.5.6.1. Company overview
8.5.6.2. Financial performance
8.5.6.3. Product benchmarking
8.5.6.4. Strategic initiatives
8.5.7. Fujifilm Corporation
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Horiba Medical
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Siemens Healthcare GmbH
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Quest Diagnostics
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 U.S. Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 4 U.S. Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 5 U.S. Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 6 North America Liver Disease Diagnostics market, region, 2021 - 2033 (USD Billion)
Table 7 North America Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 8 North America Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 9 North America Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 10 Canada Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 11 Canada Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 12 Canada Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 13 Mexico Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 14 Mexico Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 15 Mexico Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 16 Europe Liver Disease Diagnostics market, region, 2021 - 2033 (USD Billion)
Table 17 Europe Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 18 Europe Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 19 Europe Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 20 UK Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 21 UK Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 22 UK Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 23 Germany Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 24 Germany Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 25 Germany Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 26 France Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 27 France Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 28 France Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 29 Italy Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 30 Italy Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 31 Italy Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 32 Spain Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 33 Spain Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 34 Spain Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 35 Denmark Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 36 Denmark Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 37 Denmark Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 38 Sweden Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 39 Sweden Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 40 Sweden Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 41 Norway Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 42 Norway Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 43 Norway Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 44 Asia Pacific Liver Disease Diagnostics market, region, 2021 - 2033 (USD Billion)
Table 45 Asia Pacific Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 46 Asia Pacific Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 47 Asia Pacific Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 48 Japan Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 49 Japan Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 50 Japan Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 51 China Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 52 China Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 53 China Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 54 India Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 55 India Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 56 India Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 57 Australia Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 58 Australia Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 59 Australia Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 60 South Korea Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 61 South Korea Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 62 South Korea Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 63 Thailand Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 64 Thailand Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 65 Thailand Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 66 Latin America Liver Disease Diagnostics market, region, 2021 - 2033 (USD Billion)
Table 67 Latin America Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 68 Latin America Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 69 Latin America Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 70 Brazil Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 71 Brazil Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 72 Brazil Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 73 Argentina Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 74 Argentina Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 75 Argentina Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 76 MEA Liver Disease Diagnostics market, region, 2021 - 2033 (USD Billion)
Table 77 MEA Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 78 MEA Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 79 MEA Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 80 South Africa Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 81 South Africa Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 82 South Africa Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 83 Saudi Arabia Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 84 Saudi Arabia Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 85 Saudi Arabia Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
Table 86 UAE Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 87 UAE Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 88 Kuwait Liver Disease Diagnostics market, diagnosis technique, 2021 - 2033 (USD Billion)
Table 89 Kuwait Liver Disease Diagnostics market, disease, 2021 - 2033 (USD Billion)
Table 90 Kuwait Liver Disease Diagnostics market, end use, 2021 - 2033 (USD Billion)
List of Figures
Fig. 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Liver disease diagnostics: Market outlook
Figure 9 Liver disease diagnostics: Competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Liver disease diagnostics market driver impact
Figure 15 Liver disease diagnostics market restraint impact
Figure 16 Liver disease diagnostics market strategic initiatives analysis
Figure 17 Liver disease diagnostics market: disease movement analysis
Figure 18 Liver disease diagnostics market: disease outlook and key takeaways
Figure 19 NAFLD market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 20 NASH market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 21 Fibrosis market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 22 Cirrhosis market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 23 HCC market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 24 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 25 Liver disease diagnostics market: Diagnosis technique movement analysis
Figure 26 Liver disease diagnostics market: Diagnosis technique outlook and key takeaways
Figure 27 Imaging market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 28 Laboratory tests market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 29 Endoscopy market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 30 Biopsy market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 31 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 32 Liver disease diagnostics market: End use movement analysis
Figure 33 Liver disease diagnostics market: End use outlook and key takeaways
Figure 34 Hospitals market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 35 Laboratories market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 36 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 37 Global liver disease diagnostics market: Regional movement analysis
Figure 38 Global liver disease diagnostics market: Regional outlook and key takeaways
Figure 39 North America market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 40 U.S. market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 41 Canada market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 42 Mexico market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 43 Europe market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 44 UK market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 45 Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 46 France market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 47 Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 48 Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 49 Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 50 Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 51 Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 52 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 53 Japan market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 54 China market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 55 India market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 56 Australia market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 57 Thailand market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 58 South Korea market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 59 Latin America market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 60 Brazil market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 61 Argentina market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 62 Middle East and Africa. market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 63 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 64 South Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 65 UAE market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 66 Kuwait market estimates and forecasts, 2021 - 2033 (USD Billion)

Companies Mentioned

  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Randox Laboratories Ltd.
  • Boston Scientific Corporation
  • Laboratory Corporation of America Holdings
  • Fujifilm Corporation
  • Horiba Medical
  • Siemens Healthcare GmbH
  • Quest Diagnostics